![Lindsay Pino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Lindsay Pino has founded Talus Bioscience, Inc. in 2020 and currently holds the title of Chief Technology Officer.
Aktive Positionen von Lindsay Pino
Unternehmen | Position | Beginn |
---|---|---|
Talus Bioscience, Inc.
![]() Talus Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Talus Bioscience, Inc. is a company that aims to address the primary cause of cancer and other diseases, which is regulome dysfunction. The company is based in Seattle, WA, and recently raised 9.75 million in seed funding to support their efforts. The company is focused on developing a drug discovery platform that can rapidly measure and manipulate the regulome, providing a new approach to cancer therapeutics. The company has also hired a new COO, Michelle Briscoe. Talus Bioscience was founded by Alex Federation and Lindsay Pino, with Alex Federation serving as CEO since incorporation. | Gründer | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Talus Bioscience, Inc.
![]() Talus Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Talus Bioscience, Inc. is a company that aims to address the primary cause of cancer and other diseases, which is regulome dysfunction. The company is based in Seattle, WA, and recently raised 9.75 million in seed funding to support their efforts. The company is focused on developing a drug discovery platform that can rapidly measure and manipulate the regulome, providing a new approach to cancer therapeutics. The company has also hired a new COO, Michelle Briscoe. Talus Bioscience was founded by Alex Federation and Lindsay Pino, with Alex Federation serving as CEO since incorporation. | Commercial Services |